EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

B-ultrasound-guided Intrahepatic Infusion of Autologous Bone Marrow Cells for Decompensated Cirrhosis

Baochi Liu, Xiong Gao, Yuanhuai Chen, Qiqiang Dong, Jingbo Wang, Baisong Zhao

International Journal of Bone Marrow Research · 12.07.2024 · 1

DOI: 10.29328/journal.ijbmr.1001017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Bone Marrow Research, online erschienen am 12.07.2024. Verfasst von Baochi Liu und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To study the therapeutic effect of B-ultrasound-guided intrahepatic infusion of autologous bone marrow nucleated cells on decompensated cirrhosis.

Methods

To observe the clinical treatment of 75 cases of decompensated cirrhosis. Among them, 30 cases received routine liver protection and diuretic treatment. 45 cases were treated by percutaneous transhepatic infusion of autologous bone marrow nucleated cells under the guidance of B ultrasound. There were no significant differences in liver function and blood routine indexes between the two groups before treatment (p > 0.05).

Results

The indexes of liver function and blood routine at different time periods of 1 month, 3 months, 6 months, and 12 months in the conventional treatment group did not change significantly. 6 cases died of liver failure within 1 year, the fatality rate was 20%. The indexes of liver function and blood routine of percutaneous liver transhepatic infusion of autologous bone marrow nucleated cells at 1 month, 3 months, 6 months, and 12 months under the guidance of B-ultrasound were significantly better than those of the conventional treatment group (p < 0.05). One case died of gastrointestinal bleeding in the group of percutaneous transhepatic infusion of autologous bone marrow nucleated cells guided by B ultrasound, with a fatality rate of 2.5%. Compared with the conventional treatment group, there were significant differences (p < 0.05).

Conclusion

Conventional drug therapy has no obvious effect on decompensated cirrhosis. Intrahepatic infusion of bone marrow nucleated cells can significantly promote liver function reconstruction in decompensated cirrhosis.

Zitieren

APA

Liu, B., Gao, X., Chen, Y., Dong, Q., Wang, J., & Zhao, B. (2024). B-ultrasound-guided Intrahepatic Infusion of Autologous Bone Marrow Cells for Decompensated Cirrhosis. International Journal of Bone Marrow Research, 1. https://doi.org/10.29328/journal.ijbmr.1001017

Vancouver

Liu B, Gao X, Chen Y, Dong Q, Wang J, Zhao B. B-ultrasound-guided Intrahepatic Infusion of Autologous Bone Marrow Cells for Decompensated Cirrhosis. International Journal of Bone Marrow Research. 2024:1. doi:10.29328/journal.ijbmr.1001017

BibTeX
@article{Liu2024,
  author = {Liu, Baochi and Gao, Xiong and Chen, Yuanhuai and Dong, Qiqiang and Wang, Jingbo and Zhao, Baisong},
  title = {B-ultrasound-guided Intrahepatic Infusion of Autologous Bone Marrow Cells for Decompensated Cirrhosis},
  journal = {International Journal of Bone Marrow Research},
  year = {2024},
  pages = {1},
  doi = {10.29328/journal.ijbmr.1001017}
}
Kostenlos starten →